Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00462618Phase 3Completed
Phase 3, randomised, open-label trial of quetiapine in Insomnia (2 arms), sponsored by Michael E. DeBakey VA Medical Center. Primary endpoint: Pittsburgh Sleep Quality Index at 12 weeks. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00462618.